Financials
Financial year 2025
Pathologies,Hématologie,Société Médicale Pascale Frére from Nandrin, company number BE0820919512, closed financial year 2025 with a result of € 13,980 after tax. For that financial year Pathologies,Hématologie,Société Médicale Pascale Frére recorded a gross margin of € 95,183 and equity of € 19,101. Compared with financial year 2024, the result moved from € -5,184 to € 13,980. Profitable, and profit is growing. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on December 19, 2025.
€ 19,101
▼ 47% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 13,980
▲ still € 5,184 loss in 2024
Profit after tax over the fiscal year.
€ 57,891
▲ 31% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 30,600 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 14,255
▼ 36% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 13,736
▼ 41% vs 2024
€ 9,673 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.
€ 6,835
▲ 35% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 14,848
▲ 12% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 65,458 | € 75,367 | € 73,851 | € 95,183 | ▲ 29% |
| Profit after taxes | € -8,820 | € 4,245 | € -5,184 | € 13,980 | ▲ € 19,163 |
| Equity | € 91,660 | € 76,805 | € 35,721 | € 19,101 | ▼ 47% |
| Total debts | € 59,402 | € 59,011 | € 78,199 | € 100,897 | ▲ 29% |
| Cash | € 52,009 | € 44,954 | € 44,179 | € 57,891 | ▲ 31% |
| Retained profit | € 79,260 | € 64,405 | € 23,321 | € 6,701 | ▼ 71% |
| Dividend | € 0 | € 19,100 | € 35,900 | € 30,600 | ▼ 15% |
| Bank debt | € 42,097 | € 32,751 | € 23,299 | € 13,736 | ▼ 41% |
| Balance sheet total | € 151,062 | € 135,816 | € 113,920 | € 119,997 | ▲ 5% |
Key figures of Pathologies,Hématologie,Société Médicale Pascale Frére, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
What happened to Pathologies,Hématologie,Société Médicale Pascale Frére?
What happened at Pathologies,Hématologie,Société Médicale Pascale Frére in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 13,980. Source: NBB ↗
- New establishment in Verviers. KBO
- Start of the company according to the CBE. KBO
In short
From € 8,820 loss in 2022 to € 13,980 profit in 2025.
Paid € 11,026 in corporate taxes since 2022.
Best year ever: 2025, with € 13,980 profit.
Paid out € 85,600 in dividends to the owners in total.
A new publication or filing at Pathologies,Hématologie,Société Médicale Pascale Frére? We notify you, reason included.
Follow Pathologies,Hématologie,Société Médicale Pascale FréreDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Pathologies,Hématologie,Société Médicale Pascale Frére is Pascale Frere.
Directors
According to the 2025 annual accounts
Pascale Frere
Director
Establishments
Establishment units
Physical locations of this company
Rue du Neufmoulin 9
4550 Nandrin
Rue du Parc 29
4800 Verviers
Active since 14 December 2009
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0820.919.512
- VAT number
- BE 0820.919.512
- Registered office
- Rue du Neufmoulin 9, 4550 Nandrin
- Names & denominations
- Pathologies,Hématologie,Société Médicale Pascale Frére · ARCHIMED
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 23 November 2009
- Peppol
- Active · Active since 26 Mar 2026
- Activities · NACE
Activiteiten van medisch specialisten